Radioactive Iodine Therapy (Iodine I-131) for Thyroid Cancer
Precision-Focused Care for Thyroid Cancer
Theranostics Centers of America offers advanced radiopharmaceutical treatments, including Radioactive Iodine (I-131) therapy, for the effective management of thyroid cancer. This approach combines molecular imaging with targeted therapy to deliver precise treatment, reduce potential side effects, and enhance patient outcomes.
Why Consider Iodine I-131 Therapy?
Selective Targeting: I-131 is preferentially taken up by thyroid tissue, enabling precise destruction of cancerous or remaining thyroid cells while preserving surrounding healthy tissue.
Clinically Established: Supported by decades of clinical use, I-131 remains a standard treatment option for select forms of thyroid cancer.
Non-Surgical Approach: Delivered as an oral capsule or liquid, usually requiring only a short outpatient visit or brief hospital stay.
Customized Care: Treatment dosing and protocols are individualized based on each patient’s diagnosis and clinical needs.
How This Therapy Works
Patient Evaluation and Preparation: Candidates are carefully assessed to confirm suitability for I-131 therapy. Preparation may involve dietary changes and medication adjustments to optimize treatment effectiveness.
Oral Administration: I-131 is taken by mouth and absorbed by thyroid tissue, where it delivers targeted radiation to eliminate cancerous or residual thyroid cells.
Safety Guidelines: Temporary radiation safety precautions may be required after treatment to minimize exposure to others.
Ongoing Follow-Up: Continued monitoring through lab tests and imaging helps evaluate response and inform next steps in care.
Who May Benefit?
Patients with differentiated thyroid cancers, such as papillary or follicular carcinoma, following thyroid removal surgery.
Individuals experiencing recurrent or metastatic thyroid cancer that demonstrates iodine uptake.
Patients who need ablation of remaining thyroid tissue after surgery.
Theranostics Centers of America: Precision Oncology, Personalized Care
Specialized Expertise: Recognized leaders in molecular imaging and targeted radiopharmaceutical therapies for thyroid cancer.
Comprehensive Care Coordination: Dedicated support at every stage, from initial consultation through ongoing follow-up.
Accessible Locations: Multiple facilities offering convenient access to advanced, high-quality care.
Take the Next Step
If you or someone close to you has been diagnosed with thyroid cancer and may be a candidate for Radioactive Iodine (I-131) therapy, contact TCA Health Care to arrange a personalized consultation.
Appointments & Consultations: